A (Agilent Technologies) Debt-to-Asset : 0.28 (As of Jan. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Debt-to-Asset?

Agilent Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was $16 Mil. Agilent Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2025 was $3,347 Mil. Agilent Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jan. 2025 was $11,914 Mil. Agilent Technologies's debt to asset for the quarter that ended in Jan. 2025 was 0.28.

Agilent Technologies Debt-to-Asset Historical Data

The historical data trend for Agilent Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Debt-to-Asset Chart

Agilent Technologies Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Debt-to-Asset

Get a 7-Day Free Trial

0.25

0.26

0.25

0.29

Agilent Technologies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Debt-to-Asset	Get a 7-Day Free Trial															0.23	0.24	0.27	0.29	0.28

Competitive Comparison of Agilent Technologies's Debt-to-Asset

For the Diagnostics & Research subindustry, Agilent Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agilent Technologies's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Debt-to-Asset falls into.

Save

Agilent Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Agilent Technologies's Debt-to-Asset for the fiscal year that ended in Oct. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(45	+	3345)	/	11846
	=	0.29

Agilent Technologies's Debt-to-Asset for the quarter that ended in Jan. 2025 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(16	+	3347)	/	11914
	=	0.28

Agilent Technologies (NYSE:A) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Agilent Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

0HAV:UK AG8:Germany AG8:Germany AG8:Germany A1GI34:Brazil

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Executives

Rodney Gonsalves	officer: V.P., Corporate Controller	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Sue H. Rataj	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Padraig Mcdonnell	officer: Senior Vice President	5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051
Dominique Grau	officer: Senior Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Philip Binns	officer: Senior Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen	officer: CEO and President	5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
Heidi Fields	director	5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Henrik Ancher-jensen	officer: Sr. Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
George A Scangos	director	C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley	director	5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten	director	5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand	director	C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Dow R Wilson	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh	director	C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Hans Edgar Bishop	director	60 WEST 66TH STREET, 26A, NEW YORK NY 10023